Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Pharmacy and Pharmaceutical Sciences (14)
- Medical Specialties (13)
- Diseases (12)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (11)
- Medical Sciences (9)
-
- Pathological Conditions, Signs and Symptoms (8)
- Public Health (8)
- Emergency Medicine (6)
- Health Information Technology (6)
- Health and Medical Administration (6)
- Medical Education (6)
- Life Sciences (5)
- Pharmaceutics and Drug Design (5)
- Therapeutics (5)
- Chemical and Pharmacologic Phenomena (4)
- Medicinal and Pharmaceutical Chemistry (4)
- Mental and Social Health (4)
- Other Chemicals and Drugs (4)
- Patient Safety (4)
- Substance Abuse and Addiction (4)
- Amino Acids, Peptides, and Proteins (3)
- Behavior and Behavior Mechanisms (3)
- Biochemistry, Biophysics, and Structural Biology (3)
- Complex Mixtures (3)
- Medical Pharmacology (3)
- Nanotechnology (3)
- Oncology (3)
- Institution
-
- Rowan University (12)
- Southwestern Oklahoma State University (6)
- City University of New York (CUNY) (3)
- Old Dominion University (2)
- University of Kentucky (2)
-
- Chapman University (1)
- HCA Healthcare (1)
- Liberty University (1)
- Marshall University (1)
- Sacred Heart University (1)
- The British University in Egypt (1)
- The University of San Francisco (1)
- University of Nebraska at Omaha (1)
- University of North Florida (1)
- University of South Carolina (1)
- University of Tennessee Health Science Center (1)
- University of Texas Rio Grande Valley (1)
- Virginia Commonwealth University (1)
- Keyword
-
- Case Reports (2)
- Diagnosis (2)
- Drug delivery (2)
- Opioids (2)
- Pain Management (2)
-
- Pharmacology (2)
- Rural Health (2)
- Rural Pharmacy (2)
- Rural health (2)
- Rural pharmacy (2)
- Rural rocks (2)
- SWOSU Pharmacy (2)
- Substance-Related Disorders (2)
- <p>Disulfiram.</p> <p>Staphylococcus aureus infections.</p> <p>Methicillin resistance.</p> <p>Antibacterial agents.</p> <p>High performance liquid chromatography.</p> <p>Thiamin pyrophosphate.</p> <p>Enzymes.</p> <p>Coenzymes.</p> <p>Biosynthesis.</p> <p>Amino acids -- Metabolism.</p> (1)
- ARDS (1)
- Acinetobacter Infections (1)
- Acinetobacter baumannii (1)
- Acute Kidney Injury (1)
- Acute lung injury (1)
- Adrenergic beta-1 Receptor Antagonists (1)
- Adverse drug effects (1)
- Adverse reactions (1)
- Akkermansia muciniphila (1)
- Amphiphilic Peptides (1)
- Analytical Methods (1)
- Antibiotic Resistance (1)
- Antibiotic resistance (1)
- Antibody (1)
- Antidiabetic (1)
- Antimicrobial Drug Resistance (1)
- Publication
-
- Rowan-Virtua Research Day (11)
- RURAL ROCKS (6)
- Dissertations, Theses, and Capstone Projects (3)
- Bioelectrics Publications (1)
- Computer Science Faculty Publications (1)
-
- DNP Qualifying Manuscripts (1)
- Faculty Publications (1)
- HCA Healthcare Journal of Medicine (1)
- PANDION: The Osprey Journal of Research and Ideas (1)
- Pharmaceutical Sciences (MS) Theses (1)
- Pharmacy (1)
- Physician Associate Studies Faculty Publications (1)
- Research Symposium (1)
- Rowan-Virtua School of Osteopathic Medicine Departmental Research (1)
- SC Upstate Research Symposium (1)
- Senior Honors Theses (1)
- Theses and Dissertations--Clinical and Translational Science (1)
- Theses and Dissertations--Pharmacy (1)
- Theses, Dissertations and Capstones (1)
- Theses/Capstones/Creative Projects (1)
- UROP Posters (1)
- Publication Type
Articles 31 - 38 of 38
Full-Text Articles in Pharmaceutical Preparations
Characterization, Antibacterial, Antioxidant, Antidiabetic, And Anti-Inflammatory Activities Of Green Synthesized Silver Nanoparticles Using Phragmanthera Austroarabica A. G. Mill And J. A. Nyberg Extract, Shady Swidan, Dina Khodeer, Sarah Shabayek, Ali Nasr, Roaa Khinkar, Mohammed Aldurdunji, Maryam Ramadan, Jihan Badr
Characterization, Antibacterial, Antioxidant, Antidiabetic, And Anti-Inflammatory Activities Of Green Synthesized Silver Nanoparticles Using Phragmanthera Austroarabica A. G. Mill And J. A. Nyberg Extract, Shady Swidan, Dina Khodeer, Sarah Shabayek, Ali Nasr, Roaa Khinkar, Mohammed Aldurdunji, Maryam Ramadan, Jihan Badr
Pharmacy
Introduction: Diabetes mellitus is a chronic metabolic disorder that exhibited great expansion all over the world. It is becoming an epidemic disease adding a major burden to the health care system, particularly in developing countries.
Methods: The plant under investigation in the current study Phragmanthera austroarabica A. G. Mill and J. A. Nyberg is traditionally used in Saudi Arabia for the treatment of diabetes mellitus. The methanolic extract (200 mg/kg) of the plant and pure gallic acid (40 mg/kg), a major metabolite of the plant, as well as their silver nanoparticle formulae (AgNPs) were evaluated for their antidiabetic activity.
Results …
Effects Of Disulfiram On The Metabolome Of Mrsa, Surya Teja Naidu
Effects Of Disulfiram On The Metabolome Of Mrsa, Surya Teja Naidu
Theses, Dissertations and Capstones
Disulfiram, known as Antabuse®, is an oral drug for the treatment of alcohol dependence. Previous studies have indicated that disulfiram (DSF) exhibits antibacterial effects, particularly against Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Our study delves into the antibacterial mechanism of DSF in MRSA through High-Pressure Liquid Chromatography (HPLC) metabolomics, investigating the underlying mechanism of DSF effects on thiamine and amino acid metabolism. Thiamine pyrophosphate (TPP) plays a crucial role as a cofactor for critical enzymes such as transketolase, pyruvate dehydrogenase, and 2-oxoglutarate dehydrogenase. These enzymes are integral to the carbohydrate metabolism process within bacterial cells. TPP also contributes …
Self-Assembled Ternary Polypeptide Nanoparticles With Improved Biostability For Drug Delivery In Cancer Therapy, Preye Mike Agbana
Self-Assembled Ternary Polypeptide Nanoparticles With Improved Biostability For Drug Delivery In Cancer Therapy, Preye Mike Agbana
Theses and Dissertations--Pharmacy
Cancer remains a real and present threat to global health. In the United States, according to cancer statistics, almost 40% of people will be diagnosed with cancer at some point in their lifetime. Conventional chemotherapy has become the mainstay for cancer treatment option. However, chemotherapeutic agents are plagued with problems such as poor aqueous solubility, chemical degradation, Bio instability, and off-site toxicity due to non-specificity. New drug modalities are needed to tackle the ever-growing burden on cancer. In recent times, the promise of nanotechnology has aided to develop drug delivery vehicles to facilitate the administration of potent chemotherapeutics. Nanoformulations such …
Enhancing Dna-Damaging Therapy Through The Inhibition Of Dntp Synthesis Using A Synergistic Drug Combination To Treat Pancreatic Neuroendocrine Neoplasms, Jennifer Castle Md
Enhancing Dna-Damaging Therapy Through The Inhibition Of Dntp Synthesis Using A Synergistic Drug Combination To Treat Pancreatic Neuroendocrine Neoplasms, Jennifer Castle Md
Theses and Dissertations--Clinical and Translational Science
Despite clinical advances, pancreatic neuroendocrine neoplasms (pNEN) remain a difficult clinical entity to treat and can carry a poor prognosis. Systemic therapy is used to treat pNENs which are not amenable to surgical resection. Peptide receptor radionuclide therapy, a form of radiation therapy (RT) and cisplatin are two different forms of DNA-damaging therapy in current use to treat pNENs. However, their efficacy remains poor as single agents. This study aimed to increase the sensitivity of pNENs to the DNA-damaging agents, RT and cisplatin, by inhibiting deoxynucleotide triphosphate (dNTP) synthesis. Triapine, a ribonucleotide reductase inhibitor (RNRi), and ataxia telangiectasia and Rad3-related …
Efficacy And Safety Of Vibegron For The Treatment Of Overactive Bladder In Women: A Subgroup Analysis From The Double-Blind, Randomized, Controlled Empowur Trial, Diane K. Newman Dnp, Elizabeth Thomas Ms, Heather Greene Mph, Cornelia Haag-Molkenteller Md, Susann Varano Md
Efficacy And Safety Of Vibegron For The Treatment Of Overactive Bladder In Women: A Subgroup Analysis From The Double-Blind, Randomized, Controlled Empowur Trial, Diane K. Newman Dnp, Elizabeth Thomas Ms, Heather Greene Mph, Cornelia Haag-Molkenteller Md, Susann Varano Md
Physician Associate Studies Faculty Publications
Importance The international phase 3 EMPOWUR trial demonstrated efficacy and safety of vibegron, a newer b3-adrenergic receptor agonist, in adults with overactive bladder (OAB). Women are disproportionately affected by OAB, especially those with bothersome symptoms, such as urge urinary incontinence (UUI). Objective This subgroup analysis from EMPOWUR assessed efficacy and safety of vibegron in women. Study Design In EMPOWUR, patients with OAB were randomized 5:5:4 to 12 weeks of treatment with once-daily vibegron 75 mg, placebo, or tolterodine 4-mg extended release. Efficacy end points included change from baseline at week 12 in mean daily number of micturitions, UUI episodes, and …
An Acute Respiratory Distress Syndrome Drug Development Collaboration Stimulated By The Virginia Drug Discovery Consortium, John S. Lazo, Ruben M.L. Colunga-Biancatelli, Pavel A. Solopov, John D. Catravas
An Acute Respiratory Distress Syndrome Drug Development Collaboration Stimulated By The Virginia Drug Discovery Consortium, John S. Lazo, Ruben M.L. Colunga-Biancatelli, Pavel A. Solopov, John D. Catravas
Bioelectrics Publications
The genesis of most older medicinal agents has generally been empirical. During the past one and a half centuries, at least in the Western countries, discovering and developing drugs has been primarily the domain of pharmaceutical companies largely built upon concepts emerging from organic chemistry. Public sector funding for the discovery of new therapeutics has more recently stimulated local, national, and international groups to band together and focus on new human disease targets and novel treatment approaches. This Perspective describes one contemporary example of a newly formed collaboration that was simulated by a regional drug discovery consortium. University of Virginia, …
Testing The Efficacy And Synergistic Components Of Sesamol And Black Rice Extract On Human Colon Cancer Cells, Sera Lim, Philip M. Gerk
Testing The Efficacy And Synergistic Components Of Sesamol And Black Rice Extract On Human Colon Cancer Cells, Sera Lim, Philip M. Gerk
UROP Posters
Purpose: Systemic treatment of colorectal cancer involves chemotherapeutic agents which elicit serious and negative side effects from the toxicity of the drug. To address this issue, we are testing dietary supplements for their efficacy against human colon cancer cell lines and also their potential synergistic effects when combined with conventional chemotherapy. Dietary supplements (specifically sesamol and black rice extract) exhibit anticancer, anti-inflammatory, and chemo-preventive properties. Meanwhile, one of the cancer resistance mechanisms is the upregulation of drug elimination mechanisms, leading to multi-drug resistance. We hypothesize that dietary compounds will act as chemo-enhancers, thus enhancing potency of the chemotherapy drug(s) on …
Identifying The Serious Clinical Outcomes Of Adverse Reactions To Drugs By A Multi-Task Deep Learning Framework, Haochen Zhao, Peng Ni, Qichang Zhao, Xiao Liang, Di Ai, Shannon Erhardt, Jun Wang, Yaohang Li, Jiianxin Wang
Identifying The Serious Clinical Outcomes Of Adverse Reactions To Drugs By A Multi-Task Deep Learning Framework, Haochen Zhao, Peng Ni, Qichang Zhao, Xiao Liang, Di Ai, Shannon Erhardt, Jun Wang, Yaohang Li, Jiianxin Wang
Computer Science Faculty Publications
Adverse Drug Reactions (ADRs) have a direct impact on human health. As continuous pharmacovigilance and drug monitoring prove to be costly and time-consuming, computational methods have emerged as promising alternatives. However, most existing computational methods primarily focus on predicting whether or not the drug is associated with an adverse reaction and do not consider the core issue of drug benefit-risk assessment-whether the treatment outcome is serious when adverse drug reactions occur. To this end, we categorize serious clinical outcomes caused by adverse reactions to drugs into seven distinct classes and present a deep learning framework, so-called GCAP, for predicting the …